1S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Viridian Therapeutics Inc

Watchlist Manager

Watchlist

Price: 16.6 EUR 1.84% Market Closed

Market Cap: €1.1B

V	Viridian Therapeutics Inc F:1S1	US
	Mirum Pharmaceuticals Inc NASDAQ:MIRM	US
	PLC SpA MIL:PLC	IT
B	Bliss Properti Indonesia Tbk PT IDX:POSA	ID
	Professional Diversity Network Inc NASDAQ:IPDN	US
A	Asia Hotel PCL SET:ASIA	TH
S	Sjova-Almennar tryggingar hf ICEX:SJOVA	IS
	Santacruz Silver Mining Ltd F:1SZ0	CA
F	Fais Symmetochon AE ATHEX:FAIS	GR
	Planet 13 Holdings Inc F:Y7Q	US

Profitability Summary

Viridian Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-570%

Negative 3Y Average Operating Margin

-61 880%

Operating Margin is Increasing

-66 297% > -570%

Negative Net Margin

-544%

Negative 3Y Average Net Margin

-56 694%

Net Margin is Increasing

-61 903% > -544%

Negative Free Cash Flow Margin

-471%

Negative 3Y Average Free Cash Flow Margin

-46 886%

Free Cash Flow Margin is Increasing

-51 797% > -471%

Negative ROE

-66%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2 411%

ROIC is Increasing

-5 044% > -690%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.